Cardioprotection by Orotic Acid: Metabolism and Mechanism of Action

By Richards S.M.   Conyers R.A.J.   Fisher J.L.   Rosenfeldt F.L.  

Journal of Molecular and Cellular Cardiology, Vol. 29, Iss. 12, 1997-12 ,pp. : 3239-3250

Academic Press

Access to resources Recommend Favorite

Perioperative reduction of the warfarin dose

By Milligan P.E.   Banet G.A.   Gage B.F.  

The American Journal of Medicine, Vol. 115, Iss. 9, 2003-12 ,pp. : 741-742

Elsevier

Access to resources Recommend Favorite

Evaluation of GWAS-identified genetic variants for age at menarche among Chinese women

By Delahanty R.J.   Beeghly-Fadiel A.   Long J.R.   Gao Y.T.   Lu W.   Xiang Y.B.   Zheng Y.   Ji B.T.   Wen W.Q.   Cai Q.Y.   Zheng W.   Shu X.O.  

Human Reproduction, Vol. 28, Iss. 4, 2013-04 ,pp. : 1135-1143

Oxford University Press

Access to resources Recommend Favorite

Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome

By Ramos Cirilo Priscila Daniele   Rosa Fabíola Encinas   Moreira Ferraz Maria Fernanda   Rainho Cláudia Aparecida   Pontes Anaglória   Rogatto Silvia Regina  

Gynecological Endocrinology, Vol. 28, Iss. 3, 2012-03 ,pp. : 190-194

Informa Healthcare

Access to resources Recommend Favorite

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

By Carlquist John   Horne Benjamin   Muhlestein Joseph   Lappé Donald   Whiting Bryant   Kolek Matthew   Clarke Jessica   James Brent   Anderson Jeffrey  

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 3, 2006-12 ,pp. : 191-197

Springer Publishing Company

Access to resources Recommend Favorite